• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Oyster Point Pharma, Inc. - common stock (NQ:OYST)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 11.06 (41)
Ask (Size) 11.17 (20)
Prev. Close 11.17
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 26,014,621
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Health Care Becomes Most Overweighted Sector As Hedge Funds Crowd Into Magnificent 7 ↗
February 21, 2024
Goldman Sachs' Hedge Fund Trend Monitor highlights concentration in mega-caps, with optimism in AI and health care. 
Via Benzinga
Topics Artificial Intelligence
News headline image
The 7 Best Crypto and Stocks to Buy as Christmas Gifts This Year ↗
December 21, 2022
These stocks to buy as Christmas gifts provide a number of reasons for investors to rejoice this holiday season. 
Via InvestorPlace

Performance

More News

Read More
News headline image
The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond ↗
December 18, 2022
Via InvestorPlace
News headline image
OYSTER POINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Oyster Point Pharma, Inc. - OYST
December 07, 2022
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Why Viatris Stock Is Jumping Today ↗
November 07, 2022
Via The Motley Fool
News headline image
Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 02, 2022
From Oyster Point Pharma, Inc.
Via GlobeNewswire
News headline image
Better Dividend Stock: AbbVie or Viatris? ↗
November 26, 2022
Via The Motley Fool
News headline image
Oyster Point Pharma Reports Third Quarter 2022 Financial Results and Recent Business Highlights
November 10, 2022
From Oyster Point Pharma, Inc.
Via GlobeNewswire
News headline image
OYSTER POINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Oyster Point Pharma, Inc. - OYST
November 08, 2022
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Oyster Point Pharma, Inc. (Nasdaq - OYST), Benefitfocus, Inc. (Nasdaq - BNFT), Abiomed, Inc. (Nasdaq - ABMD), Atlas Corp. (NYSE - ATCO)
November 08, 2022
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Cigna To $335? Plus This Analyst Slashes PT On Six Flags Entertainment By 25% ↗
November 08, 2022
Via Benzinga
News headline image
Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday ↗
November 08, 2022
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022 ↗
November 08, 2022
Via Benzinga
News headline image
Dow Surges 400 Points; Crude Oil Down 1% ↗
November 07, 2022
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
November 07, 2022
Via Benzinga
News headline image
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday ↗
November 08, 2022
Via Benzinga
News headline image
Analyzing Oyster Point Pharma's Short Interest ↗
November 07, 2022
Via Benzinga
News headline image
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session ↗
November 07, 2022
Via Benzinga
News headline image
Dow Jumps Over 200 Points; Verve Therapeutics Shares Plummet ↗
November 07, 2022
Via Benzinga
News headline image
Oyster Point Pharma (NASDAQ: OYST) Enters Into Agreement to be Acquired by Viatris (NASDAQ: VTRS) For $11 Per Share Plus CVR Up to $2.00 Per Share
November 07, 2022
Via Spotlight Growth
News headline image
Viatris Bolsters Its Ophthalmology Franchise With Oyster Point Pharma Deal, Shares Surge ↗
November 07, 2022
Via Benzinga
News headline image
Viatris (VTRS) Stock Pops 17% on Acquisition News ↗
November 07, 2022
Via InvestorPlace
News headline image
US Stocks Mixed; Dow Rises Over 50 Points ↗
November 07, 2022
Via Benzinga
News headline image
OYST Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Oyster Point Pharma, Inc. Is Fair to Shareholders
November 07, 2022
From Halper Sadeh LLC
Via Business Wire
News headline image
Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris
November 07, 2022
From Oyster Point Pharma, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Oyster Point Pharma, Inc. - common stock publicly traded?
Yes, Oyster Point Pharma, Inc. - common stock is publicly traded.
What exchange does Oyster Point Pharma, Inc. - common stock trade on?
Oyster Point Pharma, Inc. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Oyster Point Pharma, Inc. - common stock?
The ticker symbol for Oyster Point Pharma, Inc. - common stock is OYST on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap